Rethinking the Fear Around Hormone Therapy
The reversal worth understanding — timing changes the calculation
Few areas of women's health carry as much outdated fear as hormone replacement therapy — largely because of how an early, highly publicised study was reported, and how much more nuanced the actual, current evidence has become since.
What Happened, Briefly
The original Women's Health Initiative trial, published in the early 2000s, found increased risks of certain conditions with hormone therapy in its overall study population — findings that led to a sharp, widespread drop in HRT use that persisted for years. What the initial reporting underemphasised was that the study population skewed considerably older than the typical age of menopause onset, with many participants starting hormone therapy years after menopause rather than around its onset.
The Timing Hypothesis
Starting hormone therapy earlier — in the 50s, closer to the actual menopausal transition — showed a different, better safety picture than the original headline findings suggested. A more recent analysis of the same trial's extended follow-up data found that, compared to placebo, women who started earlier had a net reduction in overall mortality, along with fewer events on a composite endpoint — a single combined score counting multiple serious health outcomes, such as heart disease, stroke, and cancer, together as one number[11]. This has become known as the "timing hypothesis": the risk-benefit balance of HRT depends substantially on when it's started relative to menopause onset, not just on whether it's used at all.
What This Means Practically
Reversal, not a free pass: this is a genuine change in the overall risk framing, not a claim that HRT is risk-free — like most medical treatments, it remains an individual risk-benefit calculation, not a universal yes or no.
Starting closer to menopause onset appears to shift the balance more favourably than starting many years after, per the timing-hypothesis analysis above.
This is a decision for a conversation with a doctor familiar with your individual history, not a decision this guide can make for you — the point of this section is specifically to correct the outdated blanket-fear framing, not to replace individualised medical advice.
Section takeaway
The blanket fear around HRT that followed the original Women's Health Initiative headlines has been substantially revised by more recent analysis showing that timing matters — for many women starting near menopause onset, the risk-benefit balance looks meaningfully different from what the original reporting suggested.